Torthaí cuardaigh - Norbert Ifrah
- 1 - 20 toradh as 84 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
IL‐34‐ and M‐CSF‐induced macrophages switch memory T cells into Th17 cells via membrane IL‐1α de réir Etienne Foucher, Simon Blanchard, Laurence Preisser, Philippe Descamps, Norbert Ifrah, Yves Delneste, Pascale Jeannin
Foilsithe / Cruthaithe 2014Artigo -
2
IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNγ de réir Etienne Foucher, Simon Blanchard, Laurence Preisser, Erwan Garo, Norbert Ifrah, Philippe Guardiola, Yves Delneste, Pascale Jeannin
Foilsithe / Cruthaithe 2013Artigo -
3
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions de réir Laurence Gamelin, M. Boisdron‐Celle, R. Delva, Véronique Guerin‐Meyer, Norbert Ifrah, Alain Morel, Érick Gamelin
Foilsithe / Cruthaithe 2004Artigo -
4
Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database de réir Nathalie Dhédin, Giraudier, Philippe Gaulard, Esperou, Norbert Ifrah, Michallet, Nöel Milpied, Rio, Cahn, Molina, Laporte, François Guilhot, Kuentz
Foilsithe / Cruthaithe 1999Artigo -
5
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative... de réir Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J.P. Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah
Foilsithe / Cruthaithe 1992Artigo -
6
Double-intensive therapy in high-risk multiple myeloma de réir JL Harousseau, Nöel Milpied, J R Laporte, P Collombat, Thierry Façon, JD Tigaud, P Casassus, François Guilhot, Norbert Ifrah, C Gandhour
Foilsithe / Cruthaithe 1992Artigo -
7
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparat... de réir A Devergié, Didier Blaise, Michel Attal, JD Tigaud, J.P. Jouet, Vernant Jp, Pierre Bordigoni, Norbert Ifrah, Charles Dauriac, J Cahn
Foilsithe / Cruthaithe 1995Artigo -
8
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative... de réir Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J P Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah
Foilsithe / Cruthaithe 1992Artigo -
9
Double-intensive therapy in high-risk multiple myeloma de réir JL Harousseau, Nöel Milpied, J R Laporte, P Collombat, Thierry Façon, JD Tigaud, Philippe Casassus, François Guilhot, Norbert Ifrah, C Gandhour
Foilsithe / Cruthaithe 1992Artigo -
10
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial de réir Christophe Willekens, Odile Blanchet, Aline Renneville, Pascale Cornillet‐Lefèbvre, Cécile Pautas, Romain Guièze, Norbert Ifrah, Hervé Dombret, Éric Jourdan, Claude Preudhomme, Nicolas Boissel
Foilsithe / Cruthaithe 2015Artigo -
11
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia de réir Jérôme Tamburini, Alexa S. Green, Valérie Bardet, Nicolas Chapuis, Sophie Park, Lise Willems, Madalina Uzunov, Norbert Ifrah, François Dreyfus, Catherine Lacombe, Patrick Mayeux, Didier Bouscary
Foilsithe / Cruthaithe 2009Artigo -
12
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use o... de réir Mathilde Hunault, P. Chevallier, Martine Delain, C.-E. Bulabois, S. Bologna, Marc Bernard, Ingrid Lafon, Jérôme Cornillon, Abdallah Maakaroun, A. Tizon, Bruno Padrazzi, Norbert Ifrah, Yves Gruel
Foilsithe / Cruthaithe 2008Artigo -
13
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody de réir Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet‐Lefèbvre, L. Gillot, Valérie Bardet, Lise Willems, Sophie Park, Alexa S. Green, Norbert Ifrah, François Dreyfus, Patrick Mayeux, C. Lacombe, Didier Bouscary
Foilsithe / Cruthaithe 2009Artigo -
14
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia de réir Patrice Chevallier, Dominique Penther, Hervé Avet‐Loiseau, Nelly Robillard, Norbert Ifrah, Beatrice Mahé, M. Hamidou, Hervé Maisonneuve, Philippe Moreau, Henri Jardel, Jean Luc Harousseau, Régis Bataille, Richard Garand
Foilsithe / Cruthaithe 2002Artigo -
15
Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia de réir Delphine Ohayon, Alessia De Chiara, Nicolas Chapuis, Céline Candalh, Julie Mocek, Jean‐Antoine Ribeil, Lamya Haddaoui, Norbert Ifrah, Olivier Hermine, Frédéric Bouillaud, Philippe Frachet, Didier Bouscary, Véronique Witko‐Sarsat
Foilsithe / Cruthaithe 2016Artigo -
16
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic... de réir Jonathan Bond, Tony Marchand, Aurore Touzart, Agata Cieślak, A. Trinquand, Laurent Sutton, I Radford-Weiss, Ludovic Lhermitte, Salvatore Spicuglia, Hervé Dombret, Elizabeth Macintyre, Norbert Ifrah, J. F. Hamel, Vahid Asnafi
Foilsithe / Cruthaithe 2016Artigo -
17
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-2... de réir Sènan Mickaël D'Almeida, Gilles Kauffenstein, Charlotte Roy, Laëtitia Basset, Loukas Papargyris, Daniel Henrion, Véronique Catros, Norbert Ifrah, Philippe Descamps, Anne Croué, Pascale Jeannin, Marc Grégoire, Yves Delneste, Julie Tabiasco
Foilsithe / Cruthaithe 2016Artigo -
18
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells de réir Dorothée Duluc, Yves Delneste, Fang Tan, Marie‐Pierre Moles, Linda Grimaud, Julien Lenoir, Laurence Preisser, Ignacio Anegón, Laurent Catala, Norbert Ifrah, Philippe Descamps, Érick Gamelin, Hugues Gascan, Mohamed Hebbar, Pascale Jeannin
Foilsithe / Cruthaithe 2007Artigo -
19
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia de réir Nicolas Chapuis, Sophie Park, Laurent Léotoing, Jérôme Tamburini, Frédèrique Verdier, Valérie Bardet, Alexa S. Green, Lise Willems, Fabrice Agou, Norbert Ifrah, François Dreyfus, Georges Bismuth, Véronique Baud, Catherine Lacombe, Patrick Mayeux, Didier Bouscary
Foilsithe / Cruthaithe 2010Artigo -
20
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients de réir Jérôme Tamburini, Caroline Elie, Valérie Bardet, Nicolas Chapuis, Sophie Park, Philippe Broët, Pascale Cornillet‐Lefèbvre, Bruno Lioure, Valérie Ugo, Odile Blanchet, Norbert Ifrah, Francis Witz, François Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary
Foilsithe / Cruthaithe 2007Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Biology
Leukemia
Immunology
Oncology
Gene
Genetics
Myeloid leukemia
Cancer research
Gastroenterology
Transplantation
Surgery
Chemotherapy
Lymphoblastic Leukemia
Biochemistry
Myeloid
Cumulative incidence
Bone marrow
Immune system
Acute lymphocytic leukemia
Cell biology
Hematopoietic stem cell transplantation
Physics
Cyclophosphamide
Stem cell
PI3K/AKT/mTOR pathway
T cell
Cancer
Multivariate analysis